Paroxetine-The Antidepressant from Hell? Probably Not, But Caution Required

Area of Science:

• Pharmacology and Toxicology
• Oncology
• Psychiatry

Background:

• Paroxetine, a widely prescribed antidepressant, has demonstrated efficacy for depression and anxiety disorders.
• Concerns have arisen regarding paroxetine's association with serious drug interactions and adverse side effects since its market introduction in 1992.

Purpose of the Study:

• To review the known side effects and drug interactions of paroxetine.
• To examine the pharmacological mechanisms underlying paroxetine's adverse effects.
• To weigh the risks of paroxetine against its therapeutic benefits.

Main Methods:

• Literature review of epidemiological studies and clinical trial data.
• Analysis of paroxetine's inhibitory effects on cytochrome P450 enzymes (2D6 and 3A4).
• Examination of paroxetine's binding affinity to the serotonin transporter.

Main Results:

• Paroxetine is associated with numerous side effects, including effects on fertility, birth defects, and cognitive function.
• It exhibits potent inhibition of P450 2D6 and 3A4 enzymes, potentially increasing oncogenesis risk.
• High affinity for the serotonin transporter contributes to its antidepressant effects but may also be linked to adverse outcomes.

Conclusions:

• Paroxetine's potent enzyme inhibition and extensive side effect profile warrant careful consideration against its therapeutic benefits in treating depression and anxiety.
• Further research is needed to fully elucidate the long-term risks and consequences associated with paroxetine use, particularly concerning oncogenesis and drug interactions.